Search Medical Condition
Please enter condition
Please choose location from dropdown

Auditory Loss and Deafness Clinical Trials

A listing of Auditory Loss and Deafness medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (22) clinical trials

The Efficacy of a Minimally Invasive Direct Cochlear Access Via the HEARO Procedure

To study the efficacy of a minimally invasive direct cochlear access via the HEARO procedure.

Phase N/A

Benefits of Tablet-based Serious Games to Promote Speech Production in Young Children With Hearing Disabilities

Learning to speak is a major challenge for children with hearing impairments. Nowadays, special devices such as conventional hearing aids, bone-anchored hearing aids (BAHA) or cochlear implants (CI) allow successful rehabilitation of patients with hearing disabilities. To obtain maximum benefit from these technical aids, instrumented hearing impaired children require specific …

Phase N/A

Multi-Center Study on Performance of the Ponto Implant System Using Minimally Invasive Ponto Surgery (in Adult Patients)

This prospective, multi-centre study funded by Oticon Medical AB will be conducted at six clinical sites in North America. Patients with a hearing loss and that are already planned for treatment with a percutaneous (through the skin) bone-anchored hearing system (BAHS) will be included in the study. The total number …

Phase N/A

Blast Exposed Veterans With Auditory Complaints

The purpose of this study is to study blast-exposed Veterans who report hearing handicap but show normal or near normal results on standard audiometric testing. The characteristics and nature of their auditory and auditory-related skills will be examined with a battery of behavioral and physiologic measures. The potential contributions of …


OTO-413 in Subjects With Speech-in-Noise Hearing Impairment

The purpose of this study is to evaluate the safety, tolerability, and exploratory efficacy of OTO-413 administered as an intratympanic injection for the treatment of speech-in-noise hearing impairment.


The BCI 602 BONEBRIDGE Post-Market Clinical Follow-up Study

The Bonebridge system using the BCI 601 is marketed since 2012. Previous prospective, multi-center, non-randomized studies on the BCI 601 Bonebridge performed in adult and paediatric populations have shown a significant improvement in terms of aided sound field (SF) thresholds, word recognition scores (WRS), speech reception thresholds (SRT) and subjective …

Phase N/A

Hearing Impairment as a Risk Factor for Dementia in Older Adults

Despite a huge increase in the knowledge about disease mechanisms in various types of dementia in recent years, no curative treatment exists at present. Results from research on disease-modifying agents have been disappointing. This has led to an increased interest in other ways to reduce the prevalence of dementia. A …

Phase N/A

Words on the Brain: Can Reading Rehabilitation for Age-Related Vision Impairment Improve Cognitive Functioning?

The research questions are the following: Does low vision rehabilitation reduce reading effort? If so, does reduced reading effort increase reading activity, If so, does increased reading activity improve cognitive (memory) functioning? The objectives are to: Evaluate cognitive functioning and memory before, and 6 and 12 months after low vision …

Phase N/A

Middle Ear Implant: Assessment of Satisfaction in the Medium Term

Currently, the data from the literature do not evaluate the use of the middle ear implant in implanted patients in the medium term (10 years and over) but only in the short term (1-5 years). Based on the observation of the absence of these data, we considered it necessary to …

Phase N/A

European Alpha-Mannosidosis Participant

Alpha-Mannosidosis is a lysosomal storage disorder of the Glycoprotein family of diseases and is closely related to Mucopolysaccharidoses.It is a rare inherited disorder that causes problems in many organs and tissues of the body. Affected individuals may have intellectual disability, distinctive facial features, and skeletal abnormalities. Characteristic facial features can …

Phase N/A